Drug Repurposing for Alzheimer’s Disease Based on Transcriptional Profiling of Human iPSC-derived Cortical Neurons

Translational Psychiatry - United Kingdom
doi 10.1038/s41398-019-0555-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons

Neuron
Neuroscience
2018English

Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons

Frontiers in Neuroscience
Neuroscience
2018English

Characterization of Human iPSC-derived Astrocytes With Potential for Disease Modeling and Drug Discovery

2019English

Human iPSC-derived Trigeminal Neurons Lack Constitutive TLR3-dependent Immunity That Protects Cortical Neurons From HSV-1 Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Using Human iPSC-Derived Neurons to Model TAU Aggregation

PLoS ONE
Multidisciplinary
2015English

Differential Maturation of the Two Regulated Secretory Pathways in Human iPSC-Derived Neurons

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2017English

Drug Repurposing in Parkinson’s Disease

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2018English

Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential

PLoS ONE
Multidisciplinary
2016English

Altered Spinogenesis in iPSC-derived Cortical Neurons From Patients With Autism Carrying De Novo SHANK3 Mutations

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy